CLINICAL_TRIALS
trial_result
· 2013-12-12
Clinical Trial Update: Lucentis for Central Retinal Vein Occlusion (CRVO) [Phase 1]
Summary
This document reports the completion of a Phase 1 trial evaluating Lucentis (ranibizumab) for central retinal vein occlusion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: California Retina Consultants | Conditions: Central Retinal Vein Occlusion | Phase 1 | Status: COMPLETED